Additionally, changes in the expression profiles of PINK1 and GPR55 were observed in correlation with survival rates in high-grade vs. low-grade gliomas, suggesting potential alterations in inflammatory and metabolic profiles [39,66,67,68,69,70,71,72]. This evidence concerns the gene PINK1 and central nervous system cancer.